|High rates of forward transmission events after acute/early HIV-1 infection|
BG Brenner, M Roger, JP Routy, D Moisi, M Ntemgwa, C Matte, JG Baril, ...
The Journal of infectious diseases 195 (7), 951-959, 2007
|A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors|
B Brenner, D Turner, M Oliveira, D Moisi, M Detorio, M Carobene, ...
Aids 17 (1), F1-F5, 2003
|Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance|
S Spira, MA Wainberg, H Loemba, D Turner, BG Brenner
Journal of Antimicrobial Chemotherapy 51 (2), 229-240, 2003
|HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture|
BG Brenner, M Oliveira, F Doualla-Bell, DD Moisi, M Ntemgwa, F Frankel, ...
Aids 20 (9), F9-F13, 2006
|Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection|
BG Brenner, JP Routy, M Petrella, D Moisi, M Oliveira, M Detorio, B Spira, ...
Journal of virology 76 (4), 1753-1761, 2002
|Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use|
H Salomon, MA Wainberg, B Brenner, Y Quan, D Rouleau, P Coté, ...
Aids 14 (2), F17-F23, 2000
|Development of antiretroviral drug resistance|
MA Wainberg, GJ Zaharatos, BG Brenner
New England Journal of Medicine 365 (7), 637-646, 2011
|Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection|
B Brenner, JP Routy, Y Quan, D Moisi, M Oliveira, D Turner, MA Wainberg
Aids 18 (12), 1653-1660, 2004
|Transmission networks of drug resistance acquired in primary/early stage HIV infection|
BG Brenner, M Roger, DD Moisi, M Oliveira, I Hardy, R Turgel, H Charest, ...
AIDS (London, England) 22 (18), 2509, 2008
|Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT|
H Loemba, B Brenner, MA Parniak, S Ma'ayan, B Spira, D Moisi, ...
Antimicrobial agents and chemotherapy 46 (7), 2087-2094, 2002
|High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens|
F Doualla-Bell, A Avalos, B Brenner, T Gaolathe, M Mine, S Gaseitsiwe, ...
Antimicrobial agents and chemotherapy 50 (12), 4182-4185, 2006
|Transmission clustering drives the onward spread of the HIV epidemic among men who have sex with men in Quebec|
BG Brenner, M Roger, D Stephens, D Moisi, I Hardy, J Weinberg, R Turgel, ...
Journal of Infectious Diseases 204 (7), 1115-1119, 2011
|Natural killer cell function in patients with acquired immunodeficiency syndrome and related diseases|
BG Brenner, A Dascal, RG Margolese, MA Wainberg
Journal of leukocyte biology 46 (1), 75-83, 1989
|Template usage is responsible for the preferential acquisition of the K65R reverse transcriptase mutation in subtype C variants of human immunodeficiency virus type 1|
D Coutsinos, CF Invernizzi, H Xu, D Moisi, M Oliveira, BG Brenner, ...
Journal of virology 83 (4), 2029-2033, 2009
|HIV drug resistance against strand transfer integrase inhibitors|
K Anstett, B Brenner, T Mesplede, MA Wainberg
Retrovirology 14 (1), 36, 2017
|Compensation by the E138K mutation in HIV-1 reverse transcriptase for deficits in viral replication capacity and enzyme processivity associated with the M184I/V mutations|
HT Xu, EL Asahchop, M Oliveira, PK Quashie, Y Quan, BG Brenner, ...
Journal of virology 85 (21), 11300-11308, 2011
|Identification of novel mutations responsible for resistance to MK-2048, a second-generation HIV-1 integrase inhibitor|
T Bar-Magen, RD Sloan, DA Donahue, BD Kuhl, A Zabeida, H Xu, ...
Journal of Virology 84 (18), 9210-9216, 2010
|Antiretroviral drug resistance in human immunodeficiency virus type 2|
ML Ntemgwa, TA Toni, BG Brenner, RJ Camacho, MA Wainberg
Antimicrobial agents and chemotherapy 53 (9), 3611-3619, 2009
|Phylogenetic inferences on HIV-1 transmission: implications for the design of prevention and treatment interventions|
B Brenner, MA Wainberg, M Roger
AIDS (London, England) 27 (7), 1045, 2013
|Modulation of stress protein (hsp27 and hsp70) expression in CD4+ lymphocytic cells following acute infection with human immunodeficiency virus type-1|
Z Wainberg, M Oliveira, S Lerner, Y Tao, BG Brenner
Virology 233 (2), 364-373, 1997